FontsA A
ContrastA A
Newsletter sign-up
I give permission for BBMRI-ERIC to send me their newsletter and emails about subjects which they think may be of interest to me. I can unsubscribe from all emails at any time. I understand that my information will be processed according to BBMRI-ERIC's privacy notice.
Home

I am looking for information as

Researcher

Industry

Patient

Citizen

Member States

BIOINDUSTRY 4.0

BIOINDUSTRY 4.0:

Topic: HORIZON-INFRA-2022-TECH-01-01 – R&D for the next generation of scientific instrumentation, tools and methods

Type of Action: HORIZON Research and Innovation Actions

Duration: 48 months

Start date: 1 January 2023

Grant agreement: 101094287

Web: www.bioindustry4.eu

Total request Grant by Consortium: € 9,439,568.25

Total request Grant by BBMRI-ERIC: €148,468.75

Linked Third Parties/BBMRI-ERIC Framework Agreement: –

Benefit/tasks for BBMRI-ERIC: BBMRI-ERIC contributes to:

WP7 (Tools for high-quality datasets, requisite for data-driven methods and services)

WP8 (Stakeholder engagement and co-design of service specifications)

Additional Information

Bioindustry 4.0 is a cutting-edge initiative bringing together academia and industry in Europe to shape the future of industrial biotechnology. Spearheaded by 6 major European research infrastructures and supported by a consortium of 25 organizations, the mission is to enhance the competitiveness of the European biotech sector globally. By refining technologies such as AI, digital twin, and cloud technologies, the project aims to empower professionals from academia and industry to collaborate and push the boundaries of bioprocess design and control – making these technologies faster, cheaper, and more sustainable.


The website was co-funded within ADOPT BBMRI-ERIC, a project that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 676550.
We use cookies to analyse the traffic on our websites. All personal data is anonymized and not shared with third parties! Click here for more information.
Accept